Sartorius Bioreactors Integrate Emerson Technology to Speed New Therapies to Market

AUSTIN, Texas (Aug. 3, 2023) Global technology and software leader Emerson has collaborated with Sartorius, a leading international biopharmaceutical company, to natively integrate Sartorius’s Biostat STR® Generation 3 family of bioreactors with Emerson’s DeltaV™ distributed control system (DCS). The Biostat STR Generation 3 for Emerson’s DeltaV, a variant of the Biostat STR Generation 3 family, is a pre-engineered solution that delivers intuitive connectivity for accelerating and simplifying the process of bringing therapies that improve patient quality-of-life to market.